학술논문

A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
Document Type
article
Source
Journal of Virus Eradication. 6(1)
Subject
Biomedical and Clinical Sciences
Immunology
Women's Health
HIV/AIDS
Sexually Transmitted Infections
Clinical Research
Infectious Diseases
Clinical Trials and Supportive Activities
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Infection
HIV
HIV cure research
HIV remission research
analytical treatment interruption
Language
Abstract
Analytic treatment interruptions (ATIs) are currently the standard for assessing the impact of experimental interventions aimed at inducing sustained antiretroviral therapy (ART)-free remission in trials related to HIV cure. ATIs are associated with substantial risk to both study participants and their sexual partner(s). Two documented HIV transmissions occurring in the context of ATIs have been recently reported, but recommendations for mitigating the risk of such events during ATIs are limited. We outline a practical approach to risk mitigation during ATI studies and describe strategies we are utilising in an upcoming clinical trial that may be applicable to other centres.